Global Alpha- Antitrypsin Deficiency Treatment Market Size, Status and Forecast 2021-2027

Publisher Name :
Date: 19-Jul-2021
No. of pages: 121
Inquire Before Buying

Market Analysis and Insights: Global Alpha- Antitrypsin Deficiency Treatment Market

The global Alpha- Antitrypsin Deficiency Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Alpha- Antitrypsin Deficiency Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Alpha- Antitrypsin Deficiency Treatment market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Alpha- Antitrypsin Deficiency Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Alpha- Antitrypsin Deficiency Treatment market.

Global Alpha- Antitrypsin Deficiency Treatment Scope and Market Size

Alpha- Antitrypsin Deficiency Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Alpha- Antitrypsin Deficiency Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type

- CT-2009

- POL-6014

- ARO-AAT

- ALNAAT-02

- Others

Segment by Application

- Clinic

- Hospital

- Others

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

By Company

- Adverum Biotechnologies, Inc.

- Alnylam Pharmaceuticals, Inc.

- Applied Genetic Technologies Corporation

- Arrowhead Pharmaceuticals, Inc.

- Carolus Therapeutics, Inc.

- Cevec Pharmaceuticals GmbH

- Dicerna Pharmaceuticals, Inc.

- Digna Biotech, S.L.

- Editas Medicine, Inc.

- Grifols, S.A.

- Inhibrx

- Intellia Therapeutics, Inc.

- International Stem Cell Corporation

- Ionis Pharmaceuticals, Inc.

- Kamada Ltd.

- Polyphor Ltd.

- ProMetic Life Sciences Inc.

- rEVO Biologics, Inc.

- Sangamo BioSciences, Inc.

Global Alpha- Antitrypsin Deficiency Treatment Market Size, Status and Forecast 2021-2027

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Alpha- Antitrypsin Deficiency Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 CT-2009
1.2.3 POL-6014
1.2.4 ARO-AAT
1.2.5 ALNAAT-02
1.2.6 Others
1.3 Market by Application
1.3.1 Global Alpha- Antitrypsin Deficiency Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Alpha- Antitrypsin Deficiency Treatment Market Perspective (2016-2027)
2.2 Alpha- Antitrypsin Deficiency Treatment Growth Trends by Regions
2.2.1 Alpha- Antitrypsin Deficiency Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Alpha- Antitrypsin Deficiency Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Alpha- Antitrypsin Deficiency Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Alpha- Antitrypsin Deficiency Treatment Industry Dynamic
2.3.1 Alpha- Antitrypsin Deficiency Treatment Market Trends
2.3.2 Alpha- Antitrypsin Deficiency Treatment Market Drivers
2.3.3 Alpha- Antitrypsin Deficiency Treatment Market Challenges
2.3.4 Alpha- Antitrypsin Deficiency Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Alpha- Antitrypsin Deficiency Treatment Players by Revenue
3.1.1 Global Top Alpha- Antitrypsin Deficiency Treatment Players by Revenue (2016-2021)
3.1.2 Global Alpha- Antitrypsin Deficiency Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Alpha- Antitrypsin Deficiency Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Alpha- Antitrypsin Deficiency Treatment Revenue
3.4 Global Alpha- Antitrypsin Deficiency Treatment Market Concentration Ratio
3.4.1 Global Alpha- Antitrypsin Deficiency Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Alpha- Antitrypsin Deficiency Treatment Revenue in 2020
3.5 Alpha- Antitrypsin Deficiency Treatment Key Players Head office and Area Served
3.6 Key Players Alpha- Antitrypsin Deficiency Treatment Product Solution and Service
3.7 Date of Enter into Alpha- Antitrypsin Deficiency Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Alpha- Antitrypsin Deficiency Treatment Breakdown Data by Type
4.1 Global Alpha- Antitrypsin Deficiency Treatment Historic Market Size by Type (2016-2021)
4.2 Global Alpha- Antitrypsin Deficiency Treatment Forecasted Market Size by Type (2022-2027)
5 Alpha- Antitrypsin Deficiency Treatment Breakdown Data by Application
5.1 Global Alpha- Antitrypsin Deficiency Treatment Historic Market Size by Application (2016-2021)
5.2 Global Alpha- Antitrypsin Deficiency Treatment Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Alpha- Antitrypsin Deficiency Treatment Market Size (2016-2027)
6.2 North America Alpha- Antitrypsin Deficiency Treatment Market Size by Type
6.2.1 North America Alpha- Antitrypsin Deficiency Treatment Market Size by Type (2016-2021)
6.2.2 North America Alpha- Antitrypsin Deficiency Treatment Market Size by Type (2022-2027)
6.2.3 North America Alpha- Antitrypsin Deficiency Treatment Market Size by Type (2016-2027)
6.3 North America Alpha- Antitrypsin Deficiency Treatment Market Size by Application
6.3.1 North America Alpha- Antitrypsin Deficiency Treatment Market Size by Application (2016-2021)
6.3.2 North America Alpha- Antitrypsin Deficiency Treatment Market Size by Application (2022-2027)
6.3.3 North America Alpha- Antitrypsin Deficiency Treatment Market Size by Application (2016-2027)
6.4 North America Alpha- Antitrypsin Deficiency Treatment Market Size by Country
6.4.1 North America Alpha- Antitrypsin Deficiency Treatment Market Size by Country (2016-2021)
6.4.2 North America Alpha- Antitrypsin Deficiency Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Alpha- Antitrypsin Deficiency Treatment Market Size (2016-2027)
7.2 Europe Alpha- Antitrypsin Deficiency Treatment Market Size by Type
7.2.1 Europe Alpha- Antitrypsin Deficiency Treatment Market Size by Type (2016-2021)
7.2.2 Europe Alpha- Antitrypsin Deficiency Treatment Market Size by Type (2022-2027)
7.2.3 Europe Alpha- Antitrypsin Deficiency Treatment Market Size by Type (2016-2027)
7.3 Europe Alpha- Antitrypsin Deficiency Treatment Market Size by Application
7.3.1 Europe Alpha- Antitrypsin Deficiency Treatment Market Size by Application (2016-2021)
7.3.2 Europe Alpha- Antitrypsin Deficiency Treatment Market Size by Application (2022-2027)
7.3.3 Europe Alpha- Antitrypsin Deficiency Treatment Market Size by Application (2016-2027)
7.4 Europe Alpha- Antitrypsin Deficiency Treatment Market Size by Country
7.4.1 Europe Alpha- Antitrypsin Deficiency Treatment Market Size by Country (2016-2021)
7.4.2 Europe Alpha- Antitrypsin Deficiency Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Market Size (2016-2027)
8.2 Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Market Size by Type
8.2.1 Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Market Size by Application
8.3.1 Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Market Size by Region
8.4.1 Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Alpha- Antitrypsin Deficiency Treatment Market Size (2016-2027)
9.2 Latin America Alpha- Antitrypsin Deficiency Treatment Market Size by Type
9.2.1 Latin America Alpha- Antitrypsin Deficiency Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Alpha- Antitrypsin Deficiency Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Alpha- Antitrypsin Deficiency Treatment Market Size by Type (2016-2027)
9.3 Latin America Alpha- Antitrypsin Deficiency Treatment Market Size by Application
9.3.1 Latin America Alpha- Antitrypsin Deficiency Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Alpha- Antitrypsin Deficiency Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Alpha- Antitrypsin Deficiency Treatment Market Size by Application (2016-2027)
9.4 Latin America Alpha- Antitrypsin Deficiency Treatment Market Size by Country
9.4.1 Latin America Alpha- Antitrypsin Deficiency Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Alpha- Antitrypsin Deficiency Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Alpha- Antitrypsin Deficiency Treatment Market Size (2016-2027)
10.2 Middle East & Africa Alpha- Antitrypsin Deficiency Treatment Market Size by Type
10.2.1 Middle East & Africa Alpha- Antitrypsin Deficiency Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Alpha- Antitrypsin Deficiency Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Alpha- Antitrypsin Deficiency Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Alpha- Antitrypsin Deficiency Treatment Market Size by Application
10.3.1 Middle East & Africa Alpha- Antitrypsin Deficiency Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Alpha- Antitrypsin Deficiency Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Alpha- Antitrypsin Deficiency Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Alpha- Antitrypsin Deficiency Treatment Market Size by Country
10.4.1 Middle East & Africa Alpha- Antitrypsin Deficiency Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Alpha- Antitrypsin Deficiency Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Adverum Biotechnologies, Inc.
11.1.1 Adverum Biotechnologies, Inc. Company Details
11.1.2 Adverum Biotechnologies, Inc. Business Overview
11.1.3 Adverum Biotechnologies, Inc. Alpha- Antitrypsin Deficiency Treatment Introduction
11.1.4 Adverum Biotechnologies, Inc. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2016-2021)
11.1.5 Adverum Biotechnologies, Inc. Recent Development
11.2 Alnylam Pharmaceuticals, Inc.
11.2.1 Alnylam Pharmaceuticals, Inc. Company Details
11.2.2 Alnylam Pharmaceuticals, Inc. Business Overview
11.2.3 Alnylam Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Introduction
11.2.4 Alnylam Pharmaceuticals, Inc. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2016-2021)
11.2.5 Alnylam Pharmaceuticals, Inc. Recent Development
11.3 Applied Genetic Technologies Corporation
11.3.1 Applied Genetic Technologies Corporation Company Details
11.3.2 Applied Genetic Technologies Corporation Business Overview
11.3.3 Applied Genetic Technologies Corporation Alpha- Antitrypsin Deficiency Treatment Introduction
11.3.4 Applied Genetic Technologies Corporation Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2016-2021)
11.3.5 Applied Genetic Technologies Corporation Recent Development
11.4 Arrowhead Pharmaceuticals, Inc.
11.4.1 Arrowhead Pharmaceuticals, Inc. Company Details
11.4.2 Arrowhead Pharmaceuticals, Inc. Business Overview
11.4.3 Arrowhead Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Introduction
11.4.4 Arrowhead Pharmaceuticals, Inc. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2016-2021)
11.4.5 Arrowhead Pharmaceuticals, Inc. Recent Development
11.5 Carolus Therapeutics, Inc.
11.5.1 Carolus Therapeutics, Inc. Company Details
11.5.2 Carolus Therapeutics, Inc. Business Overview
11.5.3 Carolus Therapeutics, Inc. Alpha- Antitrypsin Deficiency Treatment Introduction
11.5.4 Carolus Therapeutics, Inc. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2016-2021)
11.5.5 Carolus Therapeutics, Inc. Recent Development
11.6 Cevec Pharmaceuticals GmbH
11.6.1 Cevec Pharmaceuticals GmbH Company Details
11.6.2 Cevec Pharmaceuticals GmbH Business Overview
11.6.3 Cevec Pharmaceuticals GmbH Alpha- Antitrypsin Deficiency Treatment Introduction
11.6.4 Cevec Pharmaceuticals GmbH Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2016-2021)
11.6.5 Cevec Pharmaceuticals GmbH Recent Development
11.7 Dicerna Pharmaceuticals, Inc.
11.7.1 Dicerna Pharmaceuticals, Inc. Company Details
11.7.2 Dicerna Pharmaceuticals, Inc. Business Overview
11.7.3 Dicerna Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Introduction
11.7.4 Dicerna Pharmaceuticals, Inc. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2016-2021)
11.7.5 Dicerna Pharmaceuticals, Inc. Recent Development
11.8 Digna Biotech, S.L.
11.8.1 Digna Biotech, S.L. Company Details
11.8.2 Digna Biotech, S.L. Business Overview
11.8.3 Digna Biotech, S.L. Alpha- Antitrypsin Deficiency Treatment Introduction
11.8.4 Digna Biotech, S.L. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2016-2021)
11.8.5 Digna Biotech, S.L. Recent Development
11.9 Editas Medicine, Inc.
11.9.1 Editas Medicine, Inc. Company Details
11.9.2 Editas Medicine, Inc. Business Overview
11.9.3 Editas Medicine, Inc. Alpha- Antitrypsin Deficiency Treatment Introduction
11.9.4 Editas Medicine, Inc. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2016-2021)
11.9.5 Editas Medicine, Inc. Recent Development
11.10 Grifols, S.A.
11.10.1 Grifols, S.A. Company Details
11.10.2 Grifols, S.A. Business Overview
11.10.3 Grifols, S.A. Alpha- Antitrypsin Deficiency Treatment Introduction
11.10.4 Grifols, S.A. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2016-2021)
11.10.5 Grifols, S.A. Recent Development
11.11 Inhibrx
11.11.1 Inhibrx Company Details
11.11.2 Inhibrx Business Overview
11.11.3 Inhibrx Alpha- Antitrypsin Deficiency Treatment Introduction
11.11.4 Inhibrx Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2016-2021)
11.11.5 Inhibrx Recent Development
11.12 Intellia Therapeutics, Inc.
11.12.1 Intellia Therapeutics, Inc. Company Details
11.12.2 Intellia Therapeutics, Inc. Business Overview
11.12.3 Intellia Therapeutics, Inc. Alpha- Antitrypsin Deficiency Treatment Introduction
11.12.4 Intellia Therapeutics, Inc. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2016-2021)
11.12.5 Intellia Therapeutics, Inc. Recent Development
11.13 International Stem Cell Corporation
11.13.1 International Stem Cell Corporation Company Details
11.13.2 International Stem Cell Corporation Business Overview
11.13.3 International Stem Cell Corporation Alpha- Antitrypsin Deficiency Treatment Introduction
11.13.4 International Stem Cell Corporation Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2016-2021)
11.13.5 International Stem Cell Corporation Recent Development
11.14 Ionis Pharmaceuticals, Inc.
11.14.1 Ionis Pharmaceuticals, Inc. Company Details
11.14.2 Ionis Pharmaceuticals, Inc. Business Overview
11.14.3 Ionis Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Introduction
11.14.4 Ionis Pharmaceuticals, Inc. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2016-2021)
11.14.5 Ionis Pharmaceuticals, Inc. Recent Development
11.15 Kamada Ltd.
11.15.1 Kamada Ltd. Company Details
11.15.2 Kamada Ltd. Business Overview
11.15.3 Kamada Ltd. Alpha- Antitrypsin Deficiency Treatment Introduction
11.15.4 Kamada Ltd. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2016-2021)
11.15.5 Kamada Ltd. Recent Development
11.16 Polyphor Ltd.
11.16.1 Polyphor Ltd. Company Details
11.16.2 Polyphor Ltd. Business Overview
11.16.3 Polyphor Ltd. Alpha- Antitrypsin Deficiency Treatment Introduction
11.16.4 Polyphor Ltd. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2016-2021)
11.16.5 Polyphor Ltd. Recent Development
11.17 ProMetic Life Sciences Inc.
11.17.1 ProMetic Life Sciences Inc. Company Details
11.17.2 ProMetic Life Sciences Inc. Business Overview
11.17.3 ProMetic Life Sciences Inc. Alpha- Antitrypsin Deficiency Treatment Introduction
11.17.4 ProMetic Life Sciences Inc. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2016-2021)
11.17.5 ProMetic Life Sciences Inc. Recent Development
11.18 rEVO Biologics, Inc.
11.18.1 rEVO Biologics, Inc. Company Details
11.18.2 rEVO Biologics, Inc. Business Overview
11.18.3 rEVO Biologics, Inc. Alpha- Antitrypsin Deficiency Treatment Introduction
11.18.4 rEVO Biologics, Inc. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2016-2021)
11.18.5 rEVO Biologics, Inc. Recent Development
11.18 Sangamo BioSciences, Inc.
.1 Sangamo BioSciences, Inc. Company Details
.2 Sangamo BioSciences, Inc. Business Overview
.3 Sangamo BioSciences, Inc. Alpha- Antitrypsin Deficiency Treatment Introduction
.4 Sangamo BioSciences, Inc. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2016-2021)
.5 Sangamo BioSciences, Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Alpha- Antitrypsin Deficiency Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of CT-2009
Table 3. Key Players of POL-6014
Table 4. Key Players of ARO-AAT
Table 5. Key Players of ALNAAT-02
Table 6. Key Players of Others
Table 7. Global Alpha- Antitrypsin Deficiency Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Alpha- Antitrypsin Deficiency Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Alpha- Antitrypsin Deficiency Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Alpha- Antitrypsin Deficiency Treatment Market Share by Regions (2016-2021)
Table 11. Global Alpha- Antitrypsin Deficiency Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Alpha- Antitrypsin Deficiency Treatment Market Share by Regions (2022-2027)
Table 13. Alpha- Antitrypsin Deficiency Treatment Market Trends
Table 14. Alpha- Antitrypsin Deficiency Treatment Market Drivers
Table 15. Alpha- Antitrypsin Deficiency Treatment Market Challenges
Table 16. Alpha- Antitrypsin Deficiency Treatment Market Restraints
Table 17. Global Alpha- Antitrypsin Deficiency Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Alpha- Antitrypsin Deficiency Treatment Market Share by Players (2016-2021)
Table 19. Global Top Alpha- Antitrypsin Deficiency Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Alpha- Antitrypsin Deficiency Treatment as of 2020)
Table 20. Ranking of Global Top Alpha- Antitrypsin Deficiency Treatment Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Alpha- Antitrypsin Deficiency Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Alpha- Antitrypsin Deficiency Treatment Product Solution and Service
Table 24. Date of Enter into Alpha- Antitrypsin Deficiency Treatment Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Alpha- Antitrypsin Deficiency Treatment Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Alpha- Antitrypsin Deficiency Treatment Revenue Market Share by Type (2016-2021)
Table 28. Global Alpha- Antitrypsin Deficiency Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Alpha- Antitrypsin Deficiency Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Alpha- Antitrypsin Deficiency Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Alpha- Antitrypsin Deficiency Treatment Revenue Market Share by Application (2016-2021)
Table 32. Global Alpha- Antitrypsin Deficiency Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Alpha- Antitrypsin Deficiency Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Alpha- Antitrypsin Deficiency Treatment Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Alpha- Antitrypsin Deficiency Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Alpha- Antitrypsin Deficiency Treatment Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Alpha- Antitrypsin Deficiency Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Alpha- Antitrypsin Deficiency Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Alpha- Antitrypsin Deficiency Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Alpha- Antitrypsin Deficiency Treatment Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Alpha- Antitrypsin Deficiency Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Alpha- Antitrypsin Deficiency Treatment Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Alpha- Antitrypsin Deficiency Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Alpha- Antitrypsin Deficiency Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Alpha- Antitrypsin Deficiency Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Alpha- Antitrypsin Deficiency Treatment Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Alpha- Antitrypsin Deficiency Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Alpha- Antitrypsin Deficiency Treatment Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Alpha- Antitrypsin Deficiency Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Alpha- Antitrypsin Deficiency Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Alpha- Antitrypsin Deficiency Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Alpha- Antitrypsin Deficiency Treatment Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Alpha- Antitrypsin Deficiency Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Alpha- Antitrypsin Deficiency Treatment Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Alpha- Antitrypsin Deficiency Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Alpha- Antitrypsin Deficiency Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Alpha- Antitrypsin Deficiency Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 64. Adverum Biotechnologies, Inc. Company Details
Table 65. Adverum Biotechnologies, Inc. Business Overview
Table 66. Adverum Biotechnologies, Inc. Alpha- Antitrypsin Deficiency Treatment Product
Table 67. Adverum Biotechnologies, Inc. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2016-2021) & (US$ Million)
Table 68. Adverum Biotechnologies, Inc. Recent Development
Table 69. Alnylam Pharmaceuticals, Inc. Company Details
Table 70. Alnylam Pharmaceuticals, Inc. Business Overview
Table 71. Alnylam Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Product
Table 72. Alnylam Pharmaceuticals, Inc. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2016-2021) & (US$ Million)
Table 73. Alnylam Pharmaceuticals, Inc. Recent Development
Table 74. Applied Genetic Technologies Corporation Company Details
Table 75. Applied Genetic Technologies Corporation Business Overview
Table 76. Applied Genetic Technologies Corporation Alpha- Antitrypsin Deficiency Treatment Product
Table 77. Applied Genetic Technologies Corporation Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2016-2021) & (US$ Million)
Table 78. Applied Genetic Technologies Corporation Recent Development
Table 79. Arrowhead Pharmaceuticals, Inc. Company Details
Table 80. Arrowhead Pharmaceuticals, Inc. Business Overview
Table 81. Arrowhead Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Product
Table 82. Arrowhead Pharmaceuticals, Inc. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2016-2021) & (US$ Million)
Table 83. Arrowhead Pharmaceuticals, Inc. Recent Development
Table 84. Carolus Therapeutics, Inc. Company Details
Table 85. Carolus Therapeutics, Inc. Business Overview
Table 86. Carolus Therapeutics, Inc. Alpha- Antitrypsin Deficiency Treatment Product
Table 87. Carolus Therapeutics, Inc. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2016-2021) & (US$ Million)
Table 88. Carolus Therapeutics, Inc. Recent Development
Table 89. Cevec Pharmaceuticals GmbH Company Details
Table 90. Cevec Pharmaceuticals GmbH Business Overview
Table 91. Cevec Pharmaceuticals GmbH Alpha- Antitrypsin Deficiency Treatment Product
Table 92. Cevec Pharmaceuticals GmbH Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2016-2021) & (US$ Million)
Table 93. Cevec Pharmaceuticals GmbH Recent Development
Table 94. Dicerna Pharmaceuticals, Inc. Company Details
Table 95. Dicerna Pharmaceuticals, Inc. Business Overview
Table 96. Dicerna Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Product
Table 97. Dicerna Pharmaceuticals, Inc. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2016-2021) & (US$ Million)
Table 98. Dicerna Pharmaceuticals, Inc. Recent Development
Table 99. Digna Biotech, S.L. Company Details
Table 100. Digna Biotech, S.L. Business Overview
Table 101. Digna Biotech, S.L. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2016-2021) & (US$ Million)
Table 102. Digna Biotech, S.L. Recent Development
Table 103. Editas Medicine, Inc. Company Details
Table 104. Editas Medicine, Inc. Business Overview
Table 105. Editas Medicine, Inc. Alpha- Antitrypsin Deficiency Treatment Product
Table 106. Editas Medicine, Inc. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2016-2021) & (US$ Million)
Table 107. Editas Medicine, Inc. Recent Development
Table 108. Grifols, S.A. Company Details
Table 109. Grifols, S.A. Business Overview
Table 110. Grifols, S.A. Alpha- Antitrypsin Deficiency Treatment Product
Table 111. Grifols, S.A. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2016-2021) & (US$ Million)
Table 112. Grifols, S.A. Recent Development
Table 113. Inhibrx Company Details
Table 114. Inhibrx Business Overview
Table 115. Inhibrx Alpha- Antitrypsin Deficiency Treatment Product
Table 116. Inhibrx Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2016-2021) & (US$ Million)
Table 117. Inhibrx Recent Development
Table 118. Intellia Therapeutics, Inc. Company Details
Table 119. Intellia Therapeutics, Inc. Business Overview
Table 120. Intellia Therapeutics, Inc. Alpha- Antitrypsin Deficiency Treatment Product
Table 121. Intellia Therapeutics, Inc. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2016-2021) & (US$ Million)
Table 122. Intellia Therapeutics, Inc. Recent Development
Table 123. International Stem Cell Corporation Company Details
Table 124. International Stem Cell Corporation Business Overview
Table 125. International Stem Cell Corporation Alpha- Antitrypsin Deficiency Treatment Product
Table 126. International Stem Cell Corporation Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2016-2021) & (US$ Million)
Table 127. International Stem Cell Corporation Recent Development
Table 128. Ionis Pharmaceuticals, Inc. Company Details
Table 129. Ionis Pharmaceuticals, Inc. Business Overview
Table 130. Ionis Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Product
Table 131. Ionis Pharmaceuticals, Inc. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2016-2021) & (US$ Million)
Table 132. Ionis Pharmaceuticals, Inc. Recent Development
Table 133. Kamada Ltd. Company Details
Table 134. Kamada Ltd. Business Overview
Table 135. Kamada Ltd. Alpha- Antitrypsin Deficiency Treatment Product
Table 136. Kamada Ltd. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2016-2021) & (US$ Million)
Table 137. Kamada Ltd. Recent Development
Table 138. Polyphor Ltd. Company Details
Table 139. Polyphor Ltd. Business Overview
Table 140. Polyphor Ltd. Alpha- Antitrypsin Deficiency Treatment Product
Table 141. Polyphor Ltd. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2016-2021) & (US$ Million)
Table 142. Polyphor Ltd. Recent Development
Table 143. ProMetic Life Sciences Inc. Company Details
Table 144. ProMetic Life Sciences Inc. Business Overview
Table 145. ProMetic Life Sciences Inc. Alpha- Antitrypsin Deficiency Treatment Product
Table 146. ProMetic Life Sciences Inc. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2016-2021) & (US$ Million)
Table 147. ProMetic Life Sciences Inc. Recent Development
Table 148. rEVO Biologics, Inc. Company Details
Table 149. rEVO Biologics, Inc. Business Overview
Table 150. rEVO Biologics, Inc. Alpha- Antitrypsin Deficiency Treatment Product
Table 151. rEVO Biologics, Inc. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2016-2021) & (US$ Million)
Table 152. rEVO Biologics, Inc. Recent Development
Table 153. Sangamo BioSciences, Inc. Company Details
Table 154. Sangamo BioSciences, Inc. Business Overview
Table 155. Sangamo BioSciences, Inc. Alpha- Antitrypsin Deficiency Treatment Product
Table 156. Sangamo BioSciences, Inc. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2016-2021) & (US$ Million)
Table 157. Sangamo BioSciences, Inc. Recent Development
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Alpha- Antitrypsin Deficiency Treatment Market Share by Type: 2020 VS 2027
Figure 2. CT-2009 Features
Figure 3. POL-6014 Features
Figure 4. ARO-AAT Features
Figure 5. ALNAAT-02 Features
Figure 6. Others Features
Figure 7. Global Alpha- Antitrypsin Deficiency Treatment Market Share by Application: 2020 VS 2027
Figure 8. Clinic Case Studies
Figure 9. Hospital Case Studies
Figure 10. Others Case Studies
Figure 11. Alpha- Antitrypsin Deficiency Treatment Report Years Considered
Figure 12. Global Alpha- Antitrypsin Deficiency Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Alpha- Antitrypsin D
  • Global Fiberoptic Laryngoscope Market Research Report 2021
    Published: 29-Nov-2021        Price: US 2900 Onwards        Pages: 116
    The global Fiberoptic Laryngoscope market was valued at US$ 64.43 million in 2020 and is expected to reach US$ 105.99 million by the end of 2027, growing at a CAGR of 6.77% during 2021-2027. This report focuses on Fiberoptic Laryngoscope volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Fiberoptic Laryngoscope market size by analysing historical data and future prospect. Regionally, this report focuses on sev......
  • Global and Japan Beta-lactam and Beta-lactamase Inhibitors Market Size, Status and Forecast 2021-2027
    Published: 29-Nov-2021        Price: US 3900 Onwards        Pages: 173
    Market Analysis and Insights: Global and Japan Beta-lactam and Beta-lactamase Inhibitors Market This report focuses on global and Japan Beta-lactam and Beta-lactamase Inhibitors market. In 2020, the global Beta-lactam and Beta-lactamase Inhibitors market size was US$ 23715 million and it is expected to reach US$ 31774 million by the end of 2027, with a CAGR of 1.93% during 2021-2027. In Japan the Beta-lactam and Beta-lactamase Inhibitors market size is expected to grow from US$ 202......
  • Global Defibrillators Pads Market Research Report 2021
    Published: 29-Nov-2021        Price: US 2900 Onwards        Pages: 110
    The global Defibrillators Pads market was valued at US$ 167.30 million in 2020 and is expected to reach US$ 277.83 million by the end of 2027, growing at a CAGR of 6.86% during 2021-2027. This report focuses on Defibrillators Pads volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Defibrillators Pads market size by analysing historical data and future prospect. Regionally, this report focuses on several key re......
  • Hepatitis Testing/Diagnosis Market by Disease Type (Hepatitis B, Hepatitis C, Other Hepatitis), Technology (ELISA, RDT, PCR, INAAT), End User (Hospitals, Diagnostic Laboratories, Blood Banks), and Region - Global Forecast to 2026
    Published: 29-Nov-2021        Price: US 4950 Onwards        Pages: 181
    “Increasing blood transfusion and donations is expected to drive the overall growth of the hepatitis testing market.” The global hepatitis testing market is projected to reach USD 3.6 billion by 2026 from USD 2.8 billion in 2021, at a CAGR of 4.7% during the forecast period. The growth of the global hepatitis testing market is being driven by factors such as the high burden of hepatitis, increasing blood transfusion and donations, benefits of POC instrumen......
  • Global and Japan PCR Hoods Market Insights, Forecast to 2027
    Published: 18-Nov-2021        Price: US 3900 Onwards        Pages: 142
    PCR Hoods market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global PCR Hoods market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027. For Japan market, this report focuses on the PCR Hoods market size by players, by ......
  • Global and Japan PCR Hoods Market Insights, Forecast to 2027
    Published: 18-Nov-2021        Price: US 3900 Onwards        Pages: 142
    PCR Hoods market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global PCR Hoods market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027. For Japan market, this report focuses on the PCR Hoods market size by players, by ......
  • Global and United States Medical Shower Beds Market Insights, Forecast to 2027
    Published: 18-Nov-2021        Price: US 3900 Onwards        Pages: 144
    Medical Shower Beds market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Medical Shower Beds market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027. For United States market, this report focuses on the Medical S......
  • Global and United States Medical Shower Beds Market Insights, Forecast to 2027
    Published: 18-Nov-2021        Price: US 3900 Onwards        Pages: 144
    Medical Shower Beds market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Medical Shower Beds market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027. For United States market, this report focuses on the Medical S......
  • Global and Japan Orthopaedic Robotic System Market Insights, Forecast to 2027
    Published: 18-Nov-2021        Price: US 3900 Onwards        Pages: 135
    Orthopaedic Robotic System market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Orthopaedic Robotic System market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027. For Japan market, this report focuses on the Ort......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs